last month mylan rejected teva's $40 billion takeover attempt. a federal court says broadcasters will not have to turn over sensitive video programming documents as part of the government's review of the at&t direct tv deal. the court ruled that the fcc did not prove that the confidential information from cbs, disney, and others was necessary to the merger review process. a.o.l. shares are rising the most in 16 months. the company reported a 7% gain in first quarter sales and turned a profit of $7 million. a.o.l. has shifted the focus to digital advertising and sales at its platforms unit which includes digital advertising growing 21%. now, to the lead. hoover is willing to spend billions to buy one of the world's largest digital mapping services. the "new york times" says uber has submitted a bid of up to $3 billion for nokia's mapping business known as here. nokia's map business has an 80% marketshare for built in car navigation services. uber's bid is competing with another one from a group of german automakers including b.m.w., audi, and merc

we haven't heard from teva in a while. is an expectation still perhaps teva will raise its bid. we will see. he's been very aggressive in terms of articulating why a sale to teva would be a very bad idea, and why he believes the stock price of mylan, if they were to do the perigo deal -- >> there was a lot of chatter on the activist call whether he should spin off his business. there is a free for all in generics. i mentioned the ms franchise. the clock is ticking on teva. >> they migrated a lot of their patient population from 20 milligrams to 40. mylan bringing them on the 40 milligram dosage and the way it's done and patent challenges. it's a big, big percentage of profits. that being said mylan for its part the epi-pen, do you know how much money they make on the epi-pen? enormous amounts. they raised the price dramatically. over the last five years. 15% increases. it seems constantly. >> i'm getting out my epi-pen. there is a better thing than epi-pen. >> what? >> i have a better thing in my bag i always carry. >> wha

peter: teva pharmaceuticals -- julie: teva pharmaceuticals has agreed to pay $1.2 billion with the u.strade commission. it resolves claims that have to do with teva's acquisition of cell salon. teva will make $1.2 billion available to compensate purchasers including pharmacies and insurers who overpaid for the sleep disordered drug provig il. that is according to the ftc. erik: thank you very much. michael:, one last question with so many people now coming to the same conclusions that will supply, how do you get people to take notice what you're saying? what does it take to get attention from your client? michael: that is a good question. we tried to do is indicate heart of the market that people are not paying attention to -- parts of the market that people are not paying attention to. we are looking at what the chinese corruption case means for oil production in china and oil demand. we take a different perspective and we try to make sure we are looking at all the different agencies to add value and say, here is what you need to pay attention to in the next month for the oil price. e

i know that teva -- i know teva was interested in mylan. i have no idea how that will pan out.that doesn't work out, they'll make another acquisition. they almost sort of have to. >> on disney bob iger has had an amazing run as ceo. he won't be there forever. he's already identifying who his next successor could be. can they keep this juice going for another ten years? >> well i'll put it this way, he laid about as good of a foundation that a ceo could lay for a successor. the valuation is high. that is going to be an issue. they trade at 20 times blended earnings for the next year. so it's not cheap. they don't have a really good dividend. they keep raising their dividend but their stock keeps going up. who's not going to watch "star wars" and marvel in five ten years, we'll still be watching marvel and "star wars" movies. >> that i follow jon. explain cisco especially since we entered the post-chambers era. >> so cisco is easy. in technology the whole trick? looking at a decade is not to pick the biggest winner out there. it's to pick a company that will be paying you as you

pfizer recently bought hospira for $16 billion, while teva has been 40 billion dollar for mylon, whichs 40 billion for perilow. >> it's a nice environment to do m & a. companies are looking to fill their pipelines of products. >> new specialty drugs can command high prices some generic drug prices have skyrocketed. govern data shows prices for generic cholesterol drugs more than doubled the last year. >> part of it is consolidation, part of it is also the supply chain, you probably read that there are a number of plants down because of irregularities in manufacturing. the implication is fewer manufacturer's means higher prices. and i think that you're seeing it in the generics. >> with some of the backlog in manufacturing easing. generic drug prices increases have slowed this year. but they expect the rate of drug deals in the $74 billion generic drug market to continue at a fast pace. bertha coombs nightly business report new york. >> intel and altera have resumed r again off again merger talks. earlier discussions fell through because the companies were unable to agree on a price, bu

that's because they knew teva might be coming for them., it may not be teva that motivated my larkslan. an activist that's motivated a guy to continue to want to acquire. which by the way, they've been doing for years and years to quiet positive effect for shareholders. >> look at this for yesterday. bye, bye, bye. >> it's worked. >> models work. >> models work. the question is what happens there? who knows. >> the hatred. >> yeah it is. >> it is unusual. although correy simply believes they're headed down the wrong track with multiple different managements at this point and would not be in any way shape or form the right fit. >> there was a delta house who commented about the board. >> right. >> dean i love that. >> what college was that? >> oh let's see. what was the name of that college. >> we've been on fire on the animal house. >> we have. don't forget knowledge is good. all right. let's head to the scene in chicago. rick. >> well thank you very much david. today we're only up one basis point. a half a basis point at under 220 and ten

. >> ifill: the federal trade commission announced a record settlement today with teva pharmaceuticals for keeping cheaper forms of medicines off the market. the $1.2 billion settlement is a major victory against what's known in the industry as "pay for delay" deals. the f.t.c. charged that one of teva's subsidiaries illegally blocked the launch of generic versions of its sleeping pill provigil. >> woodruff: on wall street today there were modest losses as traders waited out a greek debt deadline. the dow jones industrial average lost 37 points to close at 18126. the nasdaq fell eight points the s&p 500 dropped two points. >> ifill: former three-term new york governor george pataki has become the latest republican to enter the 2016 race for the white house. pataki was governor of the heavily-democratic state during the 9/11 attacks, but hasn't held political office since 2006. today, he pledged to restore bipartisan unity, as he announced his candidacy in exeter, new hampshire. >> i have seen what americans can do when we understand we share a common dream. a common future. a common de

steve sedgewick in dresden for "nightly busines >>> teva pharmaceutical will settle abt trust charges. the ftc said one of the subsidiaries blocked a popular sleeping pill. it is considered a victory for the government in the campaign against a drug industry practice nobody as pay for -- known as pay for delay. >> we estimated that the pay for delay deals cost taxpayers billions of dollars into inflated prescriptio drug prices. >> and the settlement was a record for the agency. >> tyler, the year's biggest cancer research conference begins tomorrow in chicago where the latest advances in treatment will be discussed. one of the hot topics is the cancer therapy of the future. meg tirrell has more from inside a facility in morris plains new jersey. >> it sounds like science fiction. a new way to treat cancer that involves removing a patient's cells, equipping them in a lab with super powers and returning them to hunt and kill tumor cells. known as car t, it may be close to becoming a reality, showing in early clinical trials to help patients with leukemia that stopped responding to other

. >> montgomery county pharmaceutical power house teva will pay 1.2 billion in legal settle wment government over the wait fullness pill pro vigil. they auto caused one of the subsidiaryy companies of illegally blocking launch of again eric version and paying offer other companies. they gave generic drug makeser money ton keep the drug off the market. fts says industry so-called pay for delay deals drives up costs for patients. >> on "healthcheck" at 11 fb. a sake looking into a surgical device that was found top cause cancer in some women. and the device is a laproscopic power morslter used to remove fib roids or benign tumors in uterus and if the mass is found to be malignant the device can spread that cancer. johnson and johnson one of the main manufacturers of the device was alerted about the possible risk in 2006 and it pull the morslater off the market july of last year. >> amazon is now offering free same day delivery for prime members in 14 cities including philadelphia. the speedy shipping applies to certain category whys such as books, electronics and vacation gear. orders need to

. -- teva. they are trying to convince them of the deal.g perrigo would the attractive for pfizer. mylan is domiciled in them -- in the netherlands. mylan could go in by -- and buy sandoz. these -- this is not coming from the other companies. the one thing they are adamant about is they will not sell themselves to teva. anna: complicated stuff. thank you. manus: coming up, we speak to the ceo of easyjet. a profit for the first half. anna: >> the first time since 2002 they have turned a profit. we will talk to carolyn record about that and their forecast for the euro. that is still working in their favor. manus: stay tuned. that conversation coming up straight after this break. ♪ just because i'm away from my desk doesn't mean i'm not working. comcast business understands that. their wifi isn't just fast near the router. it's fast in the break room. fast in the conference room. fast in tom's office. fast in other tom's office. fast in the foyer [pronounced foy-yer] or is it foyer [pronounced foy-yay]? fast in the hallway. i feel like i've be

teva has yet to decide the size of any potential increase. myla says it wants to stay independent. the world's largest maker of chemicals has rejected a $45 billion takeover offer from monsanto. the offer undervalues the company and does not reflect its growth prospects. the combination would create the biggest supplier of seeds and crop chemicals. monsanto dominates the market for gmo's. that's a look at the top stories we are following on this friday. more now on the rebound in u.s. hiring. he was chief economist at rbs joins me from stamford connecticut. welcome back to "bottom line." michelle what were the main takeaways from the april employment report? shell: the biggest takeaways that everything is ok. -- michelle: the march report was so disappointing. while the april number was not gangbusters, it wasn't the same job growth we saw at the end of 2014, the number we see is very solid, even looking at the three-month trend of just under 200,000. these are solid numbers that are sufficient to bring the unemployment rate down. the big take away was the economy is not as weak as

tina -- teva settles a suit for $1.2 billion.he justice department says it has busted a ring of chinese citizens who took college entrance exams for other people. 15 people have officially been charged. prosecutors say they have passports so they can pose as a real applicants. wrongful death lawsuit filed by the family of michael brown is now moving through a federal courts. african-american was shot by a white police officer last year in ferguson, missouri. it was filed last month in a state court. it is now moving to the federal level on grounds that it deals with constitutional issues. and billionaire steve schwarzman says if he were 30 years younger, he would the an entrepreneur -- be an entrepreneur in silicon valley. he is the head of the blackstone group, and he has said that the tech sector has "so much amazing value." that is a look at the top stories in this hour. coming up in the next 30 minutes, we will have the latest in the greek bailout talks, and then the japanese yen falls to a 12 year low against the u.s. dollar

the extra cash would give teva the ability to increase its offer. last one, mylan rejected the takeover offer. a federal court says broadcasters will not have to turn oversensitive documents to the fcc as part of the government's review of the at&t directv deal. the court ruled the fcc did not deem it necessary to the process. aol shares are rising the most in 16 months. the company reported a 7% gain in first-quarter sales and turned a profit of $7 million. they have shifted their focus to digital advertising and sales. now to the lead. hoover is willing to spend billions to buy one of the world's largest digital mapping services. uber has submitted a bid of up to $3 billion for new kia's -- nokia's mapping business. uber's bid is competing with another one from a group of german automakers including bmw, audi, and mercedes-benz. they are also teaming up with baidu on their offer. joining us is cory johnson. with me in the studio is the mapping expert,. i am so glad you are here today because we are all wondering what is so special about nokia m ap

teva pharmaceuticals has agreed to pay $1.2 billion for the actions of the company it later bought.nlawfully protecting a sleep disorder drug agreements with generic drugmakers. the death toll from flooding in texas and oklahoma is climbing. officials say at least 21 people have died. 11 were missing. volunteers throughout the region are organizing search parties. it is being called the worst coastal oil spill in california in 25 years. federal agencies have ordered a pipeline company to finish the cleanup of an oil spill near santa barbara. the spill blackened beaches and created an oil slick in the pacific. erik: for almost seven years he has been the ghost of wall street. fuld the former ceo of lehman brothers. today he is making something of a return to the limelight speaking at a conference this afternoon. bill cohan is here. see, in training for fuldcket -- why would dick choose what some describe as a penny stock conference to make his return to the public eye? bill: since he is not talking to me or any of us, what i was able to surmise the writing this story is he had just a

teva proposed to buy them for $82 a share in cash and stock last points higher. mylan said it quote, grossly undervalued the company. it's pursuing it's own hostile takeovers. >> futures here are a trade lower at this hour. chief strategist at t.d. t.d. ameritrade. over the last three or four months, every time there seems to be a sell off that seems to have real rational to it and it looks like it's going to continue but it reverses the next day. i've seen it so many times and i don't know whether you can tell something from the vicks or from some other technicals that explains how one day it's down. there's just no conviction. it seems to end up around 181 or 182 on the dow and you can't put any faith in a one day move. traders are really concerned about something one day and totally elated about something else and seems like they're minor. >> it's very true joe and, in fact, if you looked since april 1st we have been through 2080 to 2130 on the s&p 500 and we bounce back and forth. like the other day you have this big, what seems like sell off yet we still hol

i wish teva best of luck and mian best of luck in their bid but at the end of the day, these businesses depend on people to execute. they depend on people to make continues tosiness gain traction and have momentum and discover new drugs. when you set up a hostile situation, you really create that blood. it takes years and years to integrate bad blood companies. as you probably know, most integration fails. i think you are stacking the odds against you when you go hostile. olivia: your business model is to make integration work. he said the generic is this is doing well. why not save mylin? brent: you can never rule anything out. we have full scale in our generics business. even in the combination of a ylin potentially from the overlap issues. we know we have size and scale and a best in classr&d pipeline so we don't feel a need to do those kind of large-scale acquisitions in generics. we are probably more suited to do tuck-ins with our generics business. we're slated to close one in england in the second quarter. i never say never to anything but it's highly unlikely. pimm: brent saunde

. >>> teva has agreed to pay $ .2 billion to settle a fight with the ftc about how it's unit treatedep disorder drug. it had been accused of paying drug makers to drop their challenge to its patent. >>> the finance ministers are holding preliminary talks at the g-7 conference to set up a meeting with the heads of state in germany next week. our cnbc news update for this hour. >>> thanks so much, sharon and welcome back to "squawk alley." we want to update you on a major deal announced in the semiconductor space this morning. avago is buying broadcom in a $37 billion deal. the largest chip deal on record. we had a conference call about the deal end moments ago. talked in great detail about the expected cost synergies, the combined company will see about $750 million in the first 18 months. avago will see this as being accretive immediately. which swi you're seeing the stock up today as the acquire. the two companies are complementary businesses, they operate in different markets but share many of the same customers, like dell, cisco, samsung of course. broadcom does call apple a custo

what i would like to know is teva. >> no, they're in a real dogfight. they're an overvalued stock.stock and i'm not going to recommend it. let's go to depender in connecticut. >> i'm great. how are you? >> i'm good. >> i just wanted to know what do you think about home depot. >> they're okay. right now there's a ce change. people are getting out of domestic stocks and going into overseas stocks. home depot is going to be fine. this is the season on home depot but i think the stock has a couple of points of risk before you take the plunge. mike in new york mike. >> hello cramer. a big booyah to you and congratulations on your wedding. >> thank you very much. >> my question is about lgnd. pharmaceutical company. >> they have moved up into a lot of specialty pharma. i like them much more. what a great quarter. doing so many good things. when they come down i'd rather see you own that one. let's go to dean in new york. dean. >> hey jim. congratulations on your marriage. >> thank you partner. thank you very much. >> happy cinco de mayo. >> almost definitely. >> listen jim i'd like to kn

and syngenta --teva is in talks to take over mylan. and new england patriots quarterback tom brady says the team championship was not tainted by the championship controversy over deflated footballs. an nfl investigation found that tom brady probably knew about it and he could be suspended and the team could face a major fine. we have less than an hour to go until the close of trading, and let's go right to our breaking news desk where senior advisor julie hyman is there. julie: we have materials technology, health care, and energy leading the game, but these were all groups in the energy sectors that were rising, and we can put this in the laps of the job report. this is just strong enough that it does support economic strength or an economic recovery, and yet just weak enough if you will that the federal reserve does not have to be, at least in theory, aggressive enough about releasing -- rising rates. this has come back up a little bit, and we are also receiving -- also seen that reflected in the dollar. all of the back-and-forth tra

because it would make sense for teva.he sandals. >> probably not. >> let's also tell you about news corp. earnings and revenue falling short of estimates. the company points to a stronger dollar and drop in add sales at its newspapers. online lending club with better than expected profit and revenue. the company getting a boost after rate cuts attracted more customers and solarcity reporting a smaller than expected loss. the company that is backed by elon musk says that solar installations were higher than expected despite bad winter weather if many key east coast markets but sales and marketing expenses soars and is sort of consensus. >> retail stocks on the move zulily hit hard but sales fall short and guidance looks weak. grow upon warning it's full year revenues falling well short of expectations. blaming a stronger dollar and weaker than expected billing which is shows the total amount collected from customers and then weightwatcher with a narrower loss than expected despite continuing to lose subscribers. the stock

amazon three years ago purchased a company called teva and they make robotics technology.nch of their distribution centers around the country over the past couple years they've been installing robotic systems to make their entire order process fulfillment center that much faster. now, an amazon spokesperson, they did confirm they are adding people at these facilities. it's not like they're laying people off but they are able to handle so much more work with less people because of the robotics technology. again, it's from the time that it's received from the time it goes out the door. >> this is an old story, right? if every single person -- if we still switched telephones by hand right every single person in america would have to be involved in switching all the phones. technology comes and jobs go away because of it. are you say it's a bad thing or hard reality? >> it's not just that but what's happening is it's happening a lot more. two other examples of good companies. there's a company call eded ross bar code. they're in texas. it will allow anything that goes through

. >> not teva? >> they don't care what it is.y'll get bigger. >> sure why not. >> cheap stocks -- oh my god, david, look at this. you know what that is? >> roller coaster? >> no. it's head and shoulders. >>> we've got the opening bell about five minutes away. more "squawk on the street" coming up. female announcer: sleep train challenged its manufacturers to offer even lower prices. but the mattress price wars ends sunday. now it's posturepedic vs. beautyrest with big savings of up to $400 off. serta icomfort and tempur-pedic go head-to-head with three years interest-free financing. plus, free same day delivery set-up and removal of your old set. when brands compete, you save! mattress price wars ends sunday at sleep train. ♪ your ticket to a better night's sleep ♪ the technology changes the design evolves the engineering advances. but the passion to drive a mercedes-benz is something that is common... to every generation of enthusiast. the 2015 dream machines, from mercedes-benz. today's icons. tomorrow's legends. visit the drea

or teva and mylan where that's the least of the issues they would have to come front. it comes up a lot, begin what happens with our own parent company. >> it's a viciously competitive deal so both stocks are moving higher. >> there is a suggestion you have to watch the currency moves here and what the dollar does because monsanto could come back at a later date depending on the movement in the dollar. >> yeah. there is no doubt they would like to do this deal. i don't believe there is a great chance they are going to come hostile. this is out there. we all know it now, syngenta having chosen to reject. it's a swiss company. i spent a lot of time lately getting to know dutch law as it relates to mylan. as for swiss takeover law, i'm not as familiar with it. i believe they mention stake holders in their response. when you hear stakeholders you know a company may have a lot more to go on in rejecting than simply saying no to price. at this point, it does appear they've been stymied yet again. >> what does this mean to you? you put it into the bigger picture. you asked if

. >>> and israel's teva pharmaceuticals disclosing a 1.35% stake in mylan. you might recall mylan rejected the offer calling it grossly undervalued. >>> tomorrow is may 29th. 5-29 that's college savings day. the big dilemma many parents wrestle with is should you fund your 401(k) for your retirement or your child's 529 plan. our senior personal finance correspondent, sharon epperson is here with his answers. i think i know the answer. >> you know the answer but some parents admit they plan to dip into the 401(k) and ira money and delay their own retirement to pay for their kid's education. it's a better alternative because who wants their kid to be saddled with a huge amount of debt. but there are ways to save for college and retirement at the same time so that you don't jeopardize your own financial security. here's a good way to strike a balance and prioritize your savings. the first dollars should go to your 401(k). do that up to the employer match. you want the tax savings. you also don't want to miss out on free money. if you don't have a 401(k) contrib

informs people they need to eat healthier because they have that teva -- same type of problems that is a huge amount of water is of massive amount of water there is a massive amount that it takes but for grey and for it -- grey and fed it to take 5,000 gallons. when you compare that to allocate that to the grave is 25 there is the big difference in consumption level. now that we approach a time where water sources are in crisis we have to reach a plant that we looked at what is produced and talk to those that to do things if you cannot cut out cold turkey then look for better sources but in general may advocate to cut down meet out of their diet. . .